Skp2-RNAi suppresses proliferation and migration of gallbladder carcinoma cells by enhancing p27 expression

Bin Zhang1, Lin-Hua Ji, Wei Liu

  • 1Department of General Surgery, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200127, China.

Abstract

Insights

Silencing S-phase kinase-associated protein-2 (Skp2) using RNA interference inhibited gallbladder carcinoma cell proliferation and migration. This targeted approach also reduced tumor growth in vivo by enhancing p27 protein expression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Gallbladder carcinoma is an aggressive malignancy with limited treatment options.
  • S-phase kinase-associated protein-2 (Skp2) is implicated in various cancers, potentially driving tumor progression.
  • Understanding Skp2's role is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the role of Skp2 in gallbladder carcinoma.
  • To determine if Skp2 depletion via RNA interference (RNAi) can inhibit cancer cell proliferation and migration.

Main Methods:

  • Lentiviral vectors were used to deliver Skp2-RNAi into gallbladder carcinoma cells (GBC-SD).
  • In vitro assays assessed proliferation, colony formation, migration, invasion, and cell cycle.
  • Real-time PCR and Western blotting analyzed Skp2 and p27 expression.
  • In vivo tumorigenicity experiments in nude mice evaluated Skp2-RNAi's effect on tumor growth.

Main Results:

  • Skp2-RNAi effectively reduced Skp2 expression in GBC-SD cells.
  • Downregulation of Skp2 led to increased p27 protein levels, without altering p27 mRNA.
  • Skp2 depletion inhibited cell proliferation, migration, and invasion in vitro.
  • Tumor weights were significantly reduced in vivo following Skp2 suppression.

Conclusions:

  • Skp2-RNAi successfully inhibited Skp2 expression in gallbladder carcinoma cells.
  • Silencing Skp2 suppressed proliferation, migration, and invasiveness.
  • These effects are mediated by enhanced p27 protein expression, suggesting a therapeutic target.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.